Yar Muhammad, Shahzadi Lubna, Farooq Ariba, Jalil Imran Saima, Cerón-Carrasco José P, den-Haan Helena, Kumar Sanjay, Peña-García Jorge, Pérez-Sánchez Horacio, Grycova Aneta, Dvorak Zdenek, Vrzal Radim
Interdisciplinary Research Center in Biomedical Materials, COMSATS Institute of Information Technology, Lahore 54000, Pakistan.
Interdisciplinary Research Center in Biomedical Materials, COMSATS Institute of Information Technology, Lahore 54000, Pakistan.
Bioorg Chem. 2017 Apr;71:285-293. doi: 10.1016/j.bioorg.2017.02.013. Epub 2017 Feb 21.
The development of biologically active molecules based on molecular recognition is an attractive and challenging task in medicinal chemistry and the molecules that can activate/deactivate certain receptors are of great medical interest. In this contribution, selected pyrimidine/piperidine derivatives were synthesized and tested for the ability to activate/deactivate Aryl hydrocarbon receptor (AhR) and Glucocorticoid receptor (GR). Tested compounds are shown to activate the receptors but to much lesser extent than positive controls, dioxin and dexamethasone for Ahr and GR, respectively. However, some of them antagonized the positive controls action. Although further in vivo studies are needed to fully characterize the bioactivities of these compounds, the reported in vitro evidences demonstrate that they might be used as the modulators of AhR and GR activities.
基于分子识别开发生物活性分子是药物化学中一项具有吸引力且富有挑战性的任务,能够激活/失活特定受体的分子具有重大医学意义。在本研究中,合成了选定的嘧啶/哌啶衍生物,并测试了它们激活/失活芳烃受体(AhR)和糖皮质激素受体(GR)的能力。测试结果表明,所测试的化合物能够激活这些受体,但激活程度远低于阳性对照,即分别针对AhR和GR的二噁英和地塞米松。然而,其中一些化合物拮抗了阳性对照的作用。尽管需要进一步的体内研究来全面表征这些化合物的生物活性,但已报道的体外证据表明,它们可能用作AhR和GR活性的调节剂。